MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 164 filers reported holding MOMENTA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $12,964,000 | +48.3% | 247,019 | -6.0% | 0.01% | +33.3% |
Q2 2020 | $8,742,000 | +43.8% | 262,751 | +17.5% | 0.01% | +28.6% |
Q1 2020 | $6,081,000 | +34.2% | 223,558 | -2.6% | 0.01% | +75.0% |
Q4 2019 | $4,531,000 | +71.7% | 229,629 | +12.8% | 0.00% | +33.3% |
Q3 2019 | $2,639,000 | +25.2% | 203,629 | +20.2% | 0.00% | +50.0% |
Q2 2019 | $2,108,000 | -14.7% | 169,341 | -0.4% | 0.00% | -33.3% |
Q1 2019 | $2,471,000 | +78.7% | 170,046 | +35.8% | 0.00% | +50.0% |
Q4 2018 | $1,383,000 | -54.2% | 125,246 | +9.1% | 0.00% | -50.0% |
Q3 2018 | $3,020,000 | +22.0% | 114,846 | -5.1% | 0.00% | +33.3% |
Q2 2018 | $2,476,000 | +4.8% | 121,063 | -7.0% | 0.00% | 0.0% |
Q1 2018 | $2,363,000 | +24.2% | 130,200 | -4.5% | 0.00% | 0.0% |
Q4 2017 | $1,903,000 | -22.8% | 136,400 | +2.4% | 0.00% | -25.0% |
Q3 2017 | $2,464,000 | +9.5% | 133,200 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $2,251,000 | +29.4% | 133,200 | +2.2% | 0.00% | +33.3% |
Q1 2017 | $1,740,000 | -15.0% | 130,300 | -4.2% | 0.00% | 0.0% |
Q4 2016 | $2,047,000 | +22.4% | 136,000 | -4.9% | 0.00% | 0.0% |
Q3 2016 | $1,672,000 | +1.3% | 143,000 | -6.5% | 0.00% | 0.0% |
Q2 2016 | $1,651,000 | +13.3% | 152,900 | -3.0% | 0.00% | +50.0% |
Q1 2016 | $1,457,000 | -51.1% | 157,700 | -21.4% | 0.00% | -60.0% |
Q4 2015 | $2,977,000 | -7.0% | 200,600 | +2.9% | 0.01% | 0.0% |
Q3 2015 | $3,200,000 | -26.0% | 195,000 | +2.9% | 0.01% | -16.7% |
Q2 2015 | $4,322,000 | +240.6% | 189,500 | +61.6% | 0.01% | +200.0% |
Q1 2015 | $1,269,000 | 0.0% | 117,300 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $1,269,000 | -4.6% | 117,300 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $1,330,000 | -6.1% | 117,300 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $1,417,000 | +9.5% | 117,300 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $1,294,000 | -37.5% | 117,300 | 0.0% | 0.00% | -33.3% |
Q4 2013 | $2,070,000 | +20.6% | 117,300 | -1.7% | 0.00% | 0.0% |
Q3 2013 | $1,717,000 | +12.4% | 119,292 | +17.7% | 0.00% | 0.0% |
Q2 2013 | $1,527,000 | – | 101,392 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |